Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingbo Shao

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Oncology|August 15, 2022
A real-world study of anlotinib as third-line or above therapy in patients with her-2 negative metastatic breast cancerYingbo Shao, Zhifen Luo, Yang Yu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 8, 2013
QM-FISH analysis of the genes involved in the G1/S checkpoint signaling pathway in triple-negative breast cancerSheng Zhang, Yingbo Shao, Guofang Hou, et al.
Breast (Edinburgh, Scotland)|December 30, 2023
Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapyYingbo Shao, Huijuan Guan, Zhifen Luo, et al.
Frontiers in Endocrinology|September 5, 2022
HER2-low expression does not affect the clinical outcomes of metastatic breast cancer treated with CDK4/6 inhibitor: A real-world studyYingbo Shao, Zhifen Luo, Yang Yu, et al.
Frontiers in Oncology|March 20, 2025
Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapyYingbo Shao, Huijuan Guan, Zhifen Luo, et al.
ACS Applied Materials & Interfaces|March 25, 2025
Dual-Additive Synergistic Complementation Electrolyte Engineering with "Job-Sharing" Modulation Mechanism for Long-Lifespan Zn-Iodine BatteriesHaidan Lu, Bowen Yin, Tianyu Zhang, et al.
Annals of Surgical Oncology|August 6, 2022
Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective AnalysisYingbo Shao, Yang Yu, Zhifen Luo, et al.
Cerebral Cortex (New York, N.Y. : 1991)|January 8, 2024
Neuropsychological insights into exercise addiction: the role of brain structure and self-efficacy in middle-older individualsFeifei Zhang, Yingbo Shao, Xiaonan Zhang, et al.
Journal of the American Chemical Society|February 26, 2024
Formaldehyde-Mediated Hydride Liberation of Alkylamines for Intermolecular Reactions in HexafluoroisopropanolShaokun Cai, Hong Tang, Bo Li, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Oncology|August 15, 2022
A real-world study of anlotinib as third-line or above therapy in patients with her-2 negative metastatic breast cancerYingbo Shao, Zhifen Luo, Yang Yu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 8, 2013
QM-FISH analysis of the genes involved in the G1/S checkpoint signaling pathway in triple-negative breast cancerSheng Zhang, Yingbo Shao, Guofang Hou, et al.
Breast (Edinburgh, Scotland)|December 30, 2023
Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapyYingbo Shao, Huijuan Guan, Zhifen Luo, et al.
Frontiers in Endocrinology|September 5, 2022
HER2-low expression does not affect the clinical outcomes of metastatic breast cancer treated with CDK4/6 inhibitor: A real-world studyYingbo Shao, Zhifen Luo, Yang Yu, et al.
Frontiers in Oncology|March 20, 2025
Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapyYingbo Shao, Huijuan Guan, Zhifen Luo, et al.
ACS Applied Materials & Interfaces|March 25, 2025
Dual-Additive Synergistic Complementation Electrolyte Engineering with "Job-Sharing" Modulation Mechanism for Long-Lifespan Zn-Iodine BatteriesHaidan Lu, Bowen Yin, Tianyu Zhang, et al.
Annals of Surgical Oncology|August 6, 2022
Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective AnalysisYingbo Shao, Yang Yu, Zhifen Luo, et al.
Cerebral Cortex (New York, N.Y. : 1991)|January 8, 2024
Neuropsychological insights into exercise addiction: the role of brain structure and self-efficacy in middle-older individualsFeifei Zhang, Yingbo Shao, Xiaonan Zhang, et al.
Journal of the American Chemical Society|February 26, 2024
Formaldehyde-Mediated Hydride Liberation of Alkylamines for Intermolecular Reactions in HexafluoroisopropanolShaokun Cai, Hong Tang, Bo Li, et al.
Pageof 3